Baylor Health Care System Foundation

Genitourinary Cancers

Any organ of the urologic and male reproductive systems is subject to urologic cancer, including the kidneys, prostate, bladder and testicles. The second-most common cancer found in American men, however, is prostate cancer. This year it will be the most diagnosed form of cancer in Dallas-Fort Worth men.

Some of the most effective weapons used to fight prostate cancer are advanced, minimally invasive treatments and patient education. Baylor excels at both. Innovative treatments like a dendritic cell-based vaccine and robotic surgery are helping more men survive, and even thrive, after prostate cancer. Awareness efforts are leading more men to step up and take charge of their health. They’re learning that wellness is a guy thing.

Areas of Need


Sometimes, the most enlightened component of care is the most human. Baylor’s patient navigation service is an example. Patient navigators help newly diagnosed patients through their treatment program by scheduling appointments, explaining each step of treatment, tracking their progress and offering a caring companion during one of the most stressful times in a person’s life.


Clinical research yields a threefold bonus of benefits. First, it offers patients access to participation in clinical research studies of medical advances, often at no charge. Second, it is our clinical research that keeps us at the forefront of cancer medicine. Finally, clinical research is critical to fulfilling our mission to serve all people.


Our medical leadership is only as strong as our ability to train the brightest minds in the field. Because of our patient volume and the vast experience of the physicians on our medical staff, we are in a unique position to offer outstanding, real-world training through fellowships.

Baylor has trained more than 42 oncology fellows since the cancer center’s founding in 1976. Moreover, we have one of the few bone marrow transplant fellowships in the nation. Fellowships, which begin after residency, allow physicians to specialize in oncology or hematology. Each of these fellows, whether they remain at Baylor or seek positions elsewhere, will affect the lives of 50,000 to 100,000 people over the course of their careers. That amounts to a significant impact on the health of our community.

Your contribution can help Baylor Health Care System Foundation fund new research and treatment options for men with genitourinary cancer. Please give online or call 214-820-3136 to discuss your gift today.

Read More

Medical Education

Training the brightest minds in the field.


Our care touches many of life's turning points.


This year, the number one cancer diagnosed in Dallas-Fort Worth men will be prostate cancer.

Genitourinary cancers make up approximately 13 percent of all newly diagnosed cancer cases at Baylor.

Only a limited number of centers nationwide are approved to offer the advanced dendritic cell-based prostate cancer vaccine Provenge®. After FDA approval, Baylor was the first to provide it.